Overview

Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

Status:
Active, not recruiting

Trial end date:
2023-05-30

Target enrollment:

Participant gender:

Summary

This study will evaluate the intraocular pressure-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty in patients with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication.

Phase:

Phase 3

Details

Lead Sponsor:

Allergan

Treatments:

Bimatoprost